FBLN3 anticorps (Middle Region)
Aperçu rapide pour FBLN3 anticorps (Middle Region) (ABIN630948)
Antigène
Voir toutes FBLN3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- EFEMP1 antibody was raised against the middle region of EFEMP1
-
Purification
- Affinity purified
-
Immunogène
- EFEMP1 antibody was raised using the middle region of EFEMP1 corresponding to a region with amino acids NENGEFYLRQTSPVSAMLVLVKSLSGPREHIVDLEMLTVSSIGTFRTSSV
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EFEMP1 Blocking Peptide, (ABIN5613311), is also available for use as a blocking control in assays to test for specificity of this EFEMP1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EFEMP1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- FBLN3 (Fibulin 3 (FBLN3))
-
Autre désignation
- EFEMP1
-
Sujet
- EFEMP1 genepans approximately 18 kb of genomic DNA and consists of 12 exons. Alternative splice patterns in the 5' UTR result in three transcript variants encoding the same extracellular matrix protein. Mutations in this gene are associated with Doyne honeycomb retinal dystrophy.
-
Poids moléculaire
- 53 kDa (MW of target protein)
-
Pathways
- EGFR Signaling Pathway
Antigène
-